Stocks
Novo Nordisk A/SNVO
NYSEHealthcarePharmaceuticals$37.96-0.16%
A Denmark-based pharmaceutical manufacturer focused on treatments for diabetes, obesity, and other chronic metabolic diseases. Its portfolio includes insulin products and GLP-1 therapies such as Ozempic and Wegovy, which have driven rapid revenue growth and reshaped the global obesity treatment mark...
Market Cap: $168.7B52W Range: $35.85 – $82.57
Congressional Interest in Novo Nordisk A/S (NVO)
12 members of Congress have disclosed 50 trades in Novo Nordisk A/S (NVO), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
12
Buys
24
Sells
26
Who in Congress Is Trading NVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-13 | Rohit Khanna | buy | $1K – $15K |
| 2025-10-31 | Lisa McClain | sell | $1K – $15K |